Dr. Howard Harrison, MD

NPI: 1700850310
Total Payments
$50,507
2024 Payments
$1,064
Companies
45
Transactions
387
Medicare Patients
6,307
Medicare Billing
$996,333

Payment Breakdown by Category

Other$39,829 (78.9%)
Food & Beverage$8,981 (17.8%)
Travel$1,417 (2.8%)
Gifts$178.20 (0.4%)
Education$101.72 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $39,829 21 78.9%
Food and Beverage $8,981 348 17.8%
Travel and Lodging $1,417 8 2.8%
Gift $178.20 3 0.4%
Education $101.72 7 0.2%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $26,961 110 $0 (2023)
SANOFI-AVENTIS U.S. LLC $15,051 36 $0 (2024)
Merck Sharp & Dohme LLC $2,043 10 $0 (2023)
Lilly USA, LLC $909.43 35 $0 (2024)
Amgen Inc. $705.79 28 $0 (2024)
Insulet Corporation $594.87 24 $0 (2023)
Dexcom, Inc. $511.28 14 $0 (2024)
Tandem Diabetes Care, Inc. $340.33 6 $0 (2022)
MannKind Corporation $334.62 6 $0 (2023)
Medtronic MiniMed, Inc. $312.20 4 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,064 27 SANOFI-AVENTIS U.S. LLC ($223.41)
2023 $959.72 31 MannKind Corporation ($179.55)
2022 $1,228 55 Insulet Corporation ($218.92)
2021 $1,018 47 Amgen Inc. ($168.30)
2020 $612.19 22 Lilly USA, LLC ($181.00)
2019 $13,644 54 Novo Nordisk Inc ($13,085)
2018 $29,162 99 SANOFI-AVENTIS U.S. LLC ($14,572)
2017 $2,820 52 Merck Sharp & Dohme Corporation ($1,996)

All Payment Transactions

387 individual payment records from CMS Open Payments — Page 1 of 16

Date Company Product Nature Form Amount Type
12/19/2024 SANOFI-AVENTIS U.S. LLC TZIELD (Biological) Food and Beverage In-kind items and services $26.88 General
Category: Endocrine & Metabolic Diseases
12/16/2024 Ascendis Pharma Inc Food and Beverage In-kind items and services $19.09 General
12/04/2024 Medtronic, Inc. INPEN SMART INSULIN DELIVERY SYSTEM (Device) Food and Beverage In-kind items and services $14.19 General
Category: Continuous Glucose Monitoring
11/26/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $18.12 General
Category: TESTOSTERONE REPLACEMENT THERAPY
11/21/2024 Amgen Inc. EVENITY (Biological), Prolia Food and Beverage In-kind items and services $7.25 General
Category: Bone Health
11/06/2024 Medtronic, Inc. INPEN SMART INSULIN DELIVERY SYSTEM (Device) Food and Beverage In-kind items and services $27.44 General
Category: Continuous Glucose Monitoring
11/04/2024 Amgen Inc. TEPEZZA (Biological) Food and Beverage In-kind items and services $29.83 General
Category: Inflammation/Rare Disease
10/08/2024 SANOFI-AVENTIS U.S. LLC TZIELD (Biological) Food and Beverage In-kind items and services $30.50 General
Category: Endocrine & Metabolic Diseases
09/30/2024 Xeris Pharmaceuticals, Inc. RECORLEV (Drug) Food and Beverage In-kind items and services $22.46 General
Category: Adrenal steroidogenesis inhibitor
09/26/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $27.52 General
Category: DIABETES
09/09/2024 BETA BIONICS, INC. iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas Food and Beverage In-kind items and services $105.34 General
Category: Automated insulin delivery system
08/22/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $27.25 General
Category: Diabetes
08/15/2024 Radius Health, Inc. Tymlos (Drug) Food and Beverage In-kind items and services $20.12 General
Category: Endocrinology
08/13/2024 Amgen Inc. TEPEZZA (Biological) Food and Beverage In-kind items and services $23.27 General
Category: Inflammation/Rare Disease
07/02/2024 Xeris Pharmaceuticals, Inc. RECORLEV (Drug) Food and Beverage In-kind items and services $22.53 General
Category: Adrenal steroidogenesis inhibitor
06/25/2024 SANOFI-AVENTIS U.S. LLC TZIELD (Biological) Food and Beverage In-kind items and services $15.99 General
Category: Endocrine & Metabolic Diseases
06/25/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $14.71 General
Category: DIABETES
05/23/2024 SANOFI-AVENTIS U.S. LLC TZIELD (Biological) Food and Beverage In-kind items and services $123.35 General
Category: Endocrine & Metabolic Diseases
05/21/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $13.02 General
Category: DIABETES
04/25/2024 ABBVIE INC. SYNTHROID (Drug) Food and Beverage In-kind items and services $13.09 General
Category: IMMUNOLOGY
04/09/2024 Amgen Inc. EVENITY (Biological) Food and Beverage In-kind items and services $111.77 General
Category: Bone Health
03/19/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $26.31 General
Category: Diabetes
03/14/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $12.49 General
Category: DIABETES
02/28/2024 Abbott Laboratories FREESTYLE LIBRE 2 (Device) Food and Beverage In-kind items and services $96.12 General
Category: Diabetes Care
02/15/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $113.15 General
Category: DIABETES

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 1,577 12,152 $522,955 $294,957
2022 11 1,691 25,241 $690,692 $372,808
2021 15 1,481 5,715 $333,152 $178,913
2020 16 1,558 5,163 $319,990 $149,655
Total Patients
6,307
Total Services
48,271
Medicare Billing
$996,333
Procedure Codes
52

All Medicare Procedures & Services

52 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J0897 Injection, denosumab, 1 mg Office 2023 102 9,960 $249,000 $181,468 72.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 637 938 $181,034 $80,679 44.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 135 151 $19,932 $8,868 44.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 43 51 $13,209 $6,669 50.5%
76536 Ultrasound scan of head and neck soft tissue Office 2023 63 63 $11,025 $5,153 46.7%
77080 Dxa bone density measurement of hip, pelvis, spine Office 2023 100 100 $20,000 $3,744 18.7%
96372 Injection of drug or substance under skin or into muscle Office 2023 113 284 $14,200 $2,992 21.1%
83036 Hemoglobin a1c level Office 2023 179 285 $7,125 $2,713 38.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 15 15 $4,380 $1,701 38.8%
82962 Blood glucose (sugar) test performed by hand-held instrument Office 2023 190 305 $3,050 $969.86 31.8%
J0897 Injection, denosumab, 1 mg Office 2022 107 9,540 $238,500 $163,603 68.6%
J3111 Injection, romosozumab-aqqg, 1 mg Office 2022 11 13,440 $201,600 $92,698 46.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 658 939 $152,286 $80,463 52.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 162 185 $20,900 $10,187 48.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 52 52 $12,881 $5,343 41.5%
76536 Ultrasound scan of head and neck soft tissue Office 2022 64 64 $11,200 $5,272 47.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 34 37 $7,955 $4,594 57.7%
77080 Dxa bone density measurement of hip, pelvis, spine Office 2022 100 100 $20,000 $3,738 18.7%
96372 Injection of drug or substance under skin or into muscle Office 2022 122 306 $15,300 $3,288 21.5%
83036 Hemoglobin a1c level Office 2022 188 286 $7,150 $2,706 37.9%
82962 Blood glucose (sugar) test performed by hand-held instrument Office 2022 193 292 $2,920 $916.21 31.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 524 854 $136,640 $76,671 56.1%
J0897 Injection, denosumab, 1 mg Office 2021 37 3,480 $87,000 $56,699 65.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 168 191 $21,392 $11,042 51.6%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 66 66 $16,170 $7,700 47.6%

About Dr. Howard Harrison, MD

Dr. Howard Harrison, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700850310.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Howard Harrison, MD has received a total of $50,507 in payments from pharmaceutical and medical device companies, with $1,064 received in 2024. These payments were reported across 387 transactions from 45 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($39,829).

As a Medicare-enrolled provider, Harrison has provided services to 6,307 Medicare beneficiaries, totaling 48,271 services with total Medicare billing of $996,333. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.

Practice Information

  • Specialty Endocrinology, Diabetes & Metabolism
  • Other Specialties Diabetes & Metabolism
  • Location Virginia Beach, VA
  • Active Since 02/13/2006
  • Last Updated 04/12/2010
  • Taxonomy Code 207RE0101X
  • Entity Type Individual
  • NPI Number 1700850310

Products in Payments

  • SOLIQUA (Drug) $12,550
  • Ozempic (Drug) $11,827
  • Tresiba (Drug) $11,165
  • Xultophy 100/3.6 (Drug) $2,325
  • TOUJEO (Drug) $2,138
  • JANUVIA (Drug) $2,019
  • Omnipod (Device) $594.87
  • JARDIANCE (Drug) $389.94
  • AFREZZA (Drug) $334.62
  • HUMULIN (Drug) $252.85
  • TZIELD (Biological) $223.41
  • t-slim insulin pump (Device) $207.04
  • EVENITY (Biological) $202.23
  • TRULICITY (Drug) $197.35
  • MOUNJARO (Drug) $190.77
  • DEXCOM CGM (Device) $184.05
  • MINIMED 780G (Device) $172.12
  • Prolia (Biological) $167.08
  • Tymlos (Biological) $162.78
  • Repatha (Biological) $156.72

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Endocrinology, Diabetes & Metabolism Doctors in Virginia Beach